{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:56:40Z","timestamp":1787849800804,"version":"build-2784847793"},"publisher-location":"Cham","reference-count":148,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783031803956","type":"print"},{"value":"9783031803963","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-3-031-80396-3_6","type":"book-chapter","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T03:59:36Z","timestamp":1742356776000},"page":"155-182","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Calcitonin as Biomarker for the Medullary Thyroid Carcinoma"],"prefix":"10.1007","author":[{"given":"Yoon Ju","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcergen","family":"Kratzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"6_CR1","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1210\/jc.2010-2359","volume":"96","author":"SR Ahmed","year":"2011","unstructured":"Ahmed SR, Ball DW (2011) Clinical review: incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment. J Clin Endocrinol Metab 96:1237\u20131245","journal-title":"J Clin Endocrinol Metab"},{"key":"6_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1210\/jc.2008-1862","volume":"94","author":"A Algeciras-Schimnich","year":"2009","unstructured":"Algeciras-Schimnich A, Preissner CM, Theobald JP, Finseth MS, Grebe SK (2009) Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 94:861\u2013868","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1055\/s-0043-122237","volume":"50","author":"S Allelein","year":"2018","unstructured":"Allelein S, Ehlers M, Morneau C, Schwartz K, Goretzki PE, Seppel T et al (2018) Measurement of basal serum calcitonin for the diagnosis of medullary thyroid cancer. Horm Metab Res 50(1):23\u201328","journal-title":"Horm Metab Res"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1210\/jc.2015-3137","volume":"101","author":"TG Alves","year":"2016","unstructured":"Alves TG, Kasamatsu TS, Yang JH, Meneghetti MC, Mendes A, Kunii IS et al (2016) Macrocalcitonin is a novel pitfall in the routine of serum calcitonin immunoassay. J Clin Endocrinol Metab 101:653\u2013658","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1056\/NEJM198101293040505","volume":"304","author":"LA Austin","year":"1981","unstructured":"Austin LA, Heath H 3rd (1981) Calcitonin: physiology and pathophysiology. N Engl J Med 304(5):269\u2013278","journal-title":"N Engl J Med"},{"key":"6_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1055\/a-1487-6449","volume":"53","author":"M B\u0103etu","year":"2021","unstructured":"B\u0103etu M, Olariu CA, Moldoveanu G, Corneci C, Badiu C (2021) Calcitonin stimulation tests: rationale, technical issues and side effects: a review. Horm Metab Res 53:355\u2013363","journal-title":"Horm Metab Res"},{"key":"6_CR8","first-page":"109","volume":"52","author":"N Barbot","year":"1991","unstructured":"Barbot N, Guyetant S, Beldent V, Akrass A, Cerf I, Perdrisot R et al (1991) Chronic autoimmune thyroiditis and C-cell hyperplasia. Study of calcitonin secretion in 24 patients. Ann Endocrinol (Paris) 52:109\u2013112","journal-title":"Ann Endocrinol (Paris)"},{"key":"6_CR10","first-page":"619","volume-title":"Principles of bone biology","author":"KL Becker","year":"2002","unstructured":"Becker KL, M\u00fcller B, Nylen ES et al (2002) Calcitonin gene family of peptides. Structure, molecular biology and effects. In: Bilezikian JP, Raisz LG, Rodan GA (eds) Principles of bone biology, 3rd edn. Academic Press, San Diego, pp 619\u2013639","edition":"3"},{"key":"6_CR11","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1210\/jc.2002-021444","volume":"89","author":"KL Becker","year":"2004","unstructured":"Becker KL, Nyl\u00e9n ES, White JC, M\u00fcller B, Snider RH Jr (2004) Clinical review 167: procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab 89:1512\u20131525","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1365-2265.1980.tb01032.x","volume":"13","author":"XY Bertagna","year":"1980","unstructured":"Bertagna XY, Bloomgarden ZT, Rabin D, Roberts LJ, Orth DN (1980) Molecular weight forms of immunoreactive calcitonin in a patient with medullary carcinoma of the thyroid: dynamic studies with calcium, pentagastrin and somatostatin. Clin Endocrinol 13(2):115\u2013123","journal-title":"Clin Endocrinol"},{"key":"6_CR13","first-page":"267","volume":"114","author":"C Bieglmayer","year":"2002","unstructured":"Bieglmayer C, Scheuba C, Niederle B, Flores J, Vierhapper H (2002) Screening for medullary thyroid carcinoma: experience with different immunoassays for human calcitonin. Wien Klin Wochenschr 114:267\u2013273","journal-title":"Wien Klin Wochenschr"},{"key":"6_CR14","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1515\/CCLM.2007.124","volume":"45","author":"C Bieglmayer","year":"2007","unstructured":"Bieglmayer C, Vierhapper H, Dudczak R, Niederle B (2007) Measurement of calcitonin by immunoassay analyzers. Clin Chem Lab Med 45:662\u2013666","journal-title":"Clin Chem Lab Med"},{"key":"6_CR15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1089\/105072503768499716","volume":"13","author":"H Bihan","year":"2003","unstructured":"Bihan H, Becker KL, Snider RH, Nylen E, Vittaz L, Lauret C et al (2003) Calcitonin precursor levels in human medullary thyroid carcinoma. Thyroid 13:819\u2013822","journal-title":"Thyroid"},{"key":"6_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/clinchem\/30.4.511","volume":"30","author":"JJ Body","year":"1984","unstructured":"Body JJ, Heath H 3rd (1984) \u201cNonspecific\u201d increases in plasma immunoreactive calcitonin in healthy individuals: discrimination from medullary thyroid carcinoma by a new extraction technique. Clin Chem 30:511\u2013514","journal-title":"Clin Chem"},{"key":"6_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1600-6143.2005.00908.x","volume":"5","author":"KA Borchhardt","year":"2005","unstructured":"Borchhardt KA, H\u00f6rl WH, Sunder-Plassmann G (2005) Reversibility of secondary hypercalcitoninemia\u2019 after kidney transplantation. Am J Transplant 5:757\u2013763","journal-title":"Am J Transplant"},{"issue":"2","key":"6_CR18","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1515\/cclm-2015-0587","volume":"54","author":"PN Bories","year":"2016","unstructured":"Bories PN, Broutin A, Delette A, Labelle G, Popovici T (2016) Comparison of the Elecsys calcitonin assay with the Immulite 1000 assay. Describing one case with heterophilic antibody interference. Clin Chem Lab Med 54(2):e45\u2013e47","journal-title":"Clin Chem Lab Med"},{"issue":"3","key":"6_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s12020-013-0019-7","volume":"45","author":"IM Boschin","year":"2014","unstructured":"Boschin IM, Torresan F, Toniato A, Zane M, Ide EC, Pennelli G et al (2014) Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications. Endocrine 45(3):448\u2013453","journal-title":"Endocrine"},{"key":"6_CR20","first-page":"1250","volume-title":"Williams textbook of endocrinology","author":"FR Bringhurst","year":"2011","unstructured":"Bringhurst FR, Demay MB, Kronenberg HM (2011) Hormones and disorders of mineral metabolism. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams textbook of endocrinology. Elsevier Saunders, Philadelphia, pp 1250\u20131252"},{"issue":"8","key":"6_CR21","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.3390\/cancers15082333","volume":"15","author":"M Broecker-Preuss","year":"2023","unstructured":"Broecker-Preuss M, Simon D, Fries M, Kornely E, Weber M, Vardarli I et al (2023) Update on calcitonin screening for medullary thyroid carcinoma and the results of a retrospective analysis of 12,984 patients with thyroid nodules. Cancers (Basel) 15(8):2333","journal-title":"Cancers (Basel)"},{"issue":"3","key":"6_CR22","first-page":"421","volume":"110","author":"E Bucht","year":"1985","unstructured":"Bucht E, T\u00f8rring O, Sj\u00f6berg HE (1985) Gel chromatography of immunoextracted plasma calcitonin in response to the calcium clamp in healthy males. Acta Endocrinol 110(3):421\u2013428","journal-title":"Acta Endocrinol"},{"issue":"2","key":"6_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000363055","volume":"3","author":"CP Camacho","year":"2014","unstructured":"Camacho CP, Lindsey SC, Kasamatsu TS, Machado AL, Martins JR, Biscolla RP et al (2014) Development and application of a novel sensitive immunometric assay for calcitonin in a large cohort of patients with medullary and differentiated thyroid cancer, thyroid nodules, and autoimmune thyroid diseases. Eur Thyroid J 3(2):117\u2013124","journal-title":"Eur Thyroid J"},{"issue":"3","key":"6_CR24","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0169-6009(92)90897-M","volume":"16","author":"AD Care","year":"1992","unstructured":"Care AD (1992) The regulation of the secretion of calcitonin. Bone Miner 16(3):182\u2013185","journal-title":"Bone Miner"},{"key":"6_CR640","doi-asserted-by":"crossref","unstructured":"Cavallo AC, Pitoia F, Roberti J, Brenzoni P, Lencioni M, Jaroslavsky MJ, Spengler E, Voogd A, Firpo C, Saco P, Pi\u00f1ero F, Negueruela M. (2024) Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma. Thyroid 34:186\u2013196","DOI":"10.1089\/thy.2023.0313"},{"key":"6_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.754565","volume":"12","author":"S Censi","year":"2021","unstructured":"Censi S, Di Stefano M, Repaci A, Benvenuti T, Manso J, Pagotto U et al (2021) Basal and calcium-stimulated procalcitonin for the diagnosis of medullary thyroid cancers: lights and shadows. Front Endocrinol (Lausanne) 12:754565","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"6_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1210\/jcem-57-4-819","volume":"57","author":"TJ Chambers","year":"1983","unstructured":"Chambers TJ, Moore A (1983) The sensitivity of isolated osteoclasts to morphological transformation by calcitonin. J Clin Endocrinol Metab 57(4):819\u2013824","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1210\/endo-116-1-234","volume":"116","author":"TJ Chambers","year":"1985","unstructured":"Chambers TJ, McSheehy PM, Thomson BM, Fuller K (1985) The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology 116(1):234\u2013239","journal-title":"Endocrinology"},{"issue":"1","key":"6_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1210\/jc.2010-0162","volume":"96","author":"G Chambon","year":"2011","unstructured":"Chambon G, Alovisetti C, Idoux-Louche C, Reynaud C, Rodier M, Guedj AM et al (2011) The use of preoperative routine measurement of basal serum thyrocalcitonin in candidates for thyroidectomy due to nodular thyroid disorders: results from 2733 consecutive patients. J Clin Endocrinol Metab 96(1):75\u201381","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1586\/erm.11.26","volume":"11","author":"T Chan","year":"2011","unstructured":"Chan T, Gu F (2011) Early diagnosis of sepsis using serum biomarkers. Expert Rev Mol Diagn 11(5):487\u2013496","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"6_CR30","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1210\/jcem.85.2.6556","volume":"85","author":"R Cohen","year":"2000","unstructured":"Cohen R, Campos JM, Sala\u00fcn C, Heshmati HM, Kraimps JL, Proye C et al (2000) Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d\u2019Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85(2):919\u2013922","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6_CR31","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1210\/jc.2011-2033","volume":"97","author":"C Colombo","year":"2012","unstructured":"Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L et al (2012) Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. J Clin Endocrinol Metab 97(3):905\u2013913","journal-title":"J Clin Endocrinol Metab"},{"key":"6_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1210\/endo-70-5-638","volume":"70","author":"DH Copp","year":"1962","unstructured":"Copp DH, Cameron EC, Cheney BA, Davidson AG, Henze KG (1962) Evidence for calcitonin-a new hormone from the parathyroid that lowers blood calcium. Endocrinology 70:638\u2013649","journal-title":"Endocrinology"},{"issue":"2","key":"6_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1210\/jc.2006-1590","volume":"92","author":"G Costante","year":"2007","unstructured":"Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S et al (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92(2):450\u2013455","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ncpendmet1023","volume":"5","author":"G Costante","year":"2009","unstructured":"Costante G, Durante C, Francis Z, Schlumberger M, Filetti S (2009) Determination of calcitonin levels in C-cell disease: clinical interest and potential pitfalls. Nat Clin Pract Endocrinol Metab 5(1):35\u201344","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"11","key":"6_CR36","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1089\/thy.2010.0297","volume":"21","author":"GH Daniels","year":"2011","unstructured":"Daniels GH (2011) Screening for medullary thyroid carcinoma with serum calcitonin measurements in patients with thyroid nodules in the United States and Canada. Thyroid 21(11):1199\u20131207","journal-title":"Thyroid"},{"issue":"5","key":"6_CR37","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/dom.12444","volume":"17","author":"GH Daniels","year":"2015","unstructured":"Daniels GH, Heged\u00fcs L, Marso SP, Nauck MA, Zinman B, Bergenstal RM et al (2015) LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial: preliminary observations. Diabetes Obes Metab 17(5):477\u2013486","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"6_CR38","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/jbmr.1869","volume":"28","author":"RA Davey","year":"2013","unstructured":"Davey RA, Findlay DM (2013) Calcitonin: physiology or fantasy? J Bone Miner Res 28(5):973\u2013979","journal-title":"J Bone Miner Res"},{"issue":"12","key":"6_CR39","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/0026-0495(71)90037-0","volume":"20","author":"LJ Deftos","year":"1971","unstructured":"Deftos LJ (1971) Immunoassay for human calcitonin. Metabolism 20(12):1122\u20131128","journal-title":"Metabolism"},{"issue":"1","key":"6_CR40","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1073\/pnas.60.1.293","volume":"60","author":"LJ Deftos","year":"1968","unstructured":"Deftos LJ, Lee MR, Potts JT Jr (1968) A radioimmunoassay for thyrocalcitonin. Proc Natl Acad Sci USA 60(1):293\u2013299","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"6_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1210\/jcem-40-3-409","volume":"40","author":"LJ Deftos","year":"1975","unstructured":"Deftos LJ, Roos BA, Bronzert D, Parthemore JG (1975) Immunochemical heterogeneity of calcitonin in plasma. J Clin Endocrinol Metab 40(3):409\u2013412","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6_CR42","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0009-8981(01)00582-4","volume":"311","author":"M d\u2019Herbomez","year":"2001","unstructured":"d\u2019Herbomez M, Leclerc L, Vantyghem MC, Fourrier F, Proye C, Wemeau JL (2001) Clinical evaluation of a new sensitive calcitonin assay: study of specificity. Clin Chim Acta 311(2):149\u2013155","journal-title":"Clin Chim Acta"},{"issue":"6","key":"6_CR43","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1530\/EJE-07-0566","volume":"157","author":"M d\u2019Herbomez","year":"2007","unstructured":"d\u2019Herbomez M, Caron P, Bauters C, Do Cao C, Schlienger JL, Sapin R et al (2007) Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 157(6):749\u2013755","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"6_CR44","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1515\/cclm-2018-1186","volume":"57","author":"F Eckelt","year":"2019","unstructured":"Eckelt F, Vogel M, Geserick M, Kirsten T, Bae YJ, Baber R et al (2019) Calcitonin measurement in pediatrics: reference ranges are gender-dependent, validation in medullary thyroid cancer and effects of thyroid diseases. Clin Chem Lab Med 57(8):1242\u20131250","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"6_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1210\/jc.2003-030550","volume":"89","author":"R Elisei","year":"2004","unstructured":"Elisei R, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L et al (2004) Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders. J Clin Endocrinol Metab 89(1):163\u2013168","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6_CR46","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1007\/s004230050160","volume":"83","author":"M Engelbach","year":"1998","unstructured":"Engelbach M, Heerdt S, G\u00f6rges R, Kunt T, Pf\u00fctzner A, Forst T et al (1998) Is there an ectopic secretion of monomeric calcitonin in the human being? Langenbeck\u2019s Arch Surg 83(6):456\u2013459","journal-title":"Langenbeck\u2019s Arch Surg"},{"issue":"5","key":"6_CR47","first-page":"1890","volume":"85","author":"M Engelbach","year":"2000","unstructured":"Engelbach M, G\u00f6rges R, Forst T, Pf\u00fctzner A, Dawood R, Heerdt S et al (2000) Improved diagnostic methods in the follow-up of medullary thyroid carcinoma by highly specific calcitonin measurements. J Clin Endocrinol Metab 85(5):1890\u20131894","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6_CR48","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1210\/jcem.82.3.3797","volume":"82","author":"MF Erdogan","year":"1997","unstructured":"Erdogan MF, G\u00fcll\u00fc S, Ba\u015fkal N, Uysal AR, Kamel N, Erdo\u011fan G (1997) Omeprazole calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab 82(3):897\u2013899","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"6_CR49","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/BF03347369","volume":"29","author":"MF Erdogan","year":"2006","unstructured":"Erdogan MF, Gursoy A, Kulaksizoglu M (2006) Long-term effects of elevated gastrin levels on calcitonin secretion. J Endocrinol Investig 29(9):771\u2013775","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"6_CR50","first-page":"39","volume":"129","author":"J Escalada","year":"1993","unstructured":"Escalada J, Teruel JL, Pav\u00f3n I, Vila T, Navarro J, Varela C (1993) Normal calcitonin response to pentagastrin stimulation in patients with chronic renal failure. Acta Endocrinol 129(1):39\u201341","journal-title":"Acta Endocrinol"},{"issue":"3","key":"6_CR51","first-page":"253","volume":"48","author":"A Faggiano","year":"2023","unstructured":"Faggiano A, Giannetta E, Modica R, Albertelli M, Barba L, Dolce P et al (2023) Calcium-stimulated calcitonin test for the diagnosis of medullary thyroid cancer: results of a multicenter study and comparison between different assays. Minerva Endocrinol (Torino) 48(3):253\u2013260","journal-title":"Minerva Endocrinol (Torino)"},{"issue":"15","key":"6_CR52","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1055\/a-0585-8097","volume":"143","author":"K Frank-Raue","year":"2018","unstructured":"Frank-Raue K, Schott M, Raue F (2018) Recommendation for calcitonin screening in nodular Goiter. Dtsch Med Wochenschr 143(15):1065\u20131069, German","journal-title":"Dtsch Med Wochenschr"},{"issue":"1","key":"6_CR53","doi-asserted-by":"publisher","first-page":"232","DOI":"10.7326\/0003-4819-121-3-199408010-00012","volume":"121","author":"JW Freston","year":"1994","unstructured":"Freston JW (1994) Omeprazole, hypergastrinemia, and gastric carcinoid tumors. Ann Intern Med 121(1):232\u2013233","journal-title":"Ann Intern Med"},{"issue":"3","key":"6_CR54","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1152\/physrev.1995.75.3.429","volume":"75","author":"PA Friedmann","year":"1995","unstructured":"Friedmann PA, Gesek FA (1995) Cellular calcium transport in renal epithelia: measurement, mechanisms and regulation. Physiol Rev 75(3):429\u2013471","journal-title":"Physiol Rev"},{"issue":"1","key":"6_CR55","first-page":"49","volume":"2","author":"L Fugazzola","year":"2013","unstructured":"Fugazzola L (2013) Stimulated calcitonin cut-offs by different tests. Eur Thyroid J 2(1):49\u201356","journal-title":"Eur Thyroid J"},{"issue":"3","key":"6_CR56","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s40618-020-01356-9","volume":"44","author":"L Fugazzola","year":"2021","unstructured":"Fugazzola L, Di Stefano M, Censi S, Repaci A, Colombo C, Grimaldi F et al (2021) Basal and stimulated calcitonin for the diagnosis of medullary thyroid cancer: updated thresholds and safety assessment. J Endocrinol Investig 44(3):587\u2013597","journal-title":"J Endocrinol Investig"},{"issue":"4","key":"6_CR57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000183020","volume":"34","author":"S Garancini","year":"1983","unstructured":"Garancini S, Ballada L, Roncari G, Gastaldi L (1983) Calcitonin in chronic renal failure. Nephron 34(4):224\u2013227","journal-title":"Nephron"},{"issue":"11","key":"6_CR58","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1210\/endo.136.11.7588259","volume":"136","author":"JE Garrett","year":"1995","unstructured":"Garrett JE, Tamir H, Kifor O, Simin RT, Rogers KV, Mithal A et al (1995) Calcitonin-secreting cells of the thyroid express an extracellular calcitonin receptor gene. Endocrinology 136(11):5202\u20135211","journal-title":"Endocrinology"},{"key":"6_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/10024.GL","volume":"16 Suppl 1","author":"H Gharib","year":"2010","unstructured":"Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Heged\u00fcs L et al (2010) AACE\/AME\/ETA task force on thyroid nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 16 Suppl 1:1\u201343","journal-title":"Endocr Pract"},{"issue":"5","key":"6_CR60","doi-asserted-by":"publisher","first-page":"622","DOI":"10.4158\/EP161208.GL","volume":"22","author":"H Gharib","year":"2016","unstructured":"Gharib H, Papini E, Garber JR, Suick DS, Harrell RM, Heged\u00fcs L et al (2016) American association of clinical endocrinologists, American college of endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules\u20142016 update. Endocr Pract 22(5):622\u2013639. https:\/\/doi.org\/10.4158\/EP161208.GL","journal-title":"Endocr Pract"},{"issue":"6","key":"6_CR61","doi-asserted-by":"publisher","first-page":"R197","DOI":"10.1530\/EJE-20-0506","volume":"183","author":"E Giannetta","year":"2020","unstructured":"Giannetta E, Guarnotta V, Altieri B, Sciammarella C, Guadagno E, Malandrino P et al (2020) ENDOCRINE TUMOURS: calcitonin in thyroid and extra-thyroid neuroendocrine neoplasms: the two-faced Janus. Eur J Endocrinol 183(6):R197\u2013R215","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"6_CR62","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/bjs.4875","volume":"92","author":"H Gibelin","year":"2005","unstructured":"Gibelin H, Essique D, Jones C, Levillain P, Mar\u00e9chaud R, Kraimps JL (2005) Increased calcitonin level in thyroid nodules without medullary carcinoma. Br J Surg 92(5):574\u2013578","journal-title":"Br J Surg"},{"issue":"3","key":"6_CR63","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1055\/s-0031-1301290","volume":"120","author":"L Giovanella","year":"2012","unstructured":"Giovanella L (2012) Serum procalcitonin and calcitonin normal values before and after calcium gluconate infusion. Exp Clin Endocrinol Diabetes 120(3):169\u2013170","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"5","key":"6_CR64","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1515\/cclm-2011-0920","volume":"50","author":"L Giovanella","year":"2012","unstructured":"Giovanella L, Imperiali M, Ferrari A, Palumbo A, Lippa L, Peretti A et al (2012) Thyroid volume influences serum calcitonin levels in a thyroid-healthy population: results of a 3-assay, 519 subjects study. Clin Chem Lab Med 50(5):895\u2013900","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"6_CR65","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1515\/cclm-2017-0993","volume":"56","author":"L Giovanella","year":"2018","unstructured":"Giovanella L, Giordani I, Imperiali M, Orlandi F, Trimboli P (2018a) Measuring procalcitonin to overcome heterophilic-antibody-induced spurious hypercalcitoninemia. Clin Chem Lab Med 56(8):e191\u2013e193","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"6_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12934","volume":"48","author":"L Giovanella","year":"2018","unstructured":"Giovanella L, Imperiali M, Piccardo A, Taborelli M, Verburg FA, Daurizio F et al (2018b) Procalcitonin measurement to screen medullary thyroid carcinoma: a prospective evaluation in a series of 2705 patients with thyroid nodules. Eur J Clin Investig 48(6):e12934","journal-title":"Eur J Clin Investig"},{"issue":"4","key":"6_CR67","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1515\/cclm-2020-1424","volume":"59","author":"L Giovanella","year":"2020","unstructured":"Giovanella L, Fontana M, Keller F, Verburg FA, Ceriani L (2020) Clinical performance of calcitonin and procalcitonin Elecsys\u00ae immunoassays in patients with medullary thyroid carcinoma. Clin Chem Lab Med 59(4):743\u2013747","journal-title":"Clin Chem Lab Med"},{"issue":"12","key":"6_CR68","first-page":"3634","volume":"106","author":"L Giovanella","year":"2021","unstructured":"Giovanella L, Garo ML, Ceriani L, Paone G, Campenni\u2019 A, D\u2019Aurizio F (2021) Procalcitonin as an alternative tumor marker of medullary thyroid carcinoma. J Clin Endocrinol Metab 106(12):3634\u20133643","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"6_CR69","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1172\/JCI108956","volume":"61","author":"D Goltzman","year":"1978","unstructured":"Goltzman D, Tischler AS (1978) Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture. J Clin Invest 61(2):449\u2013458","journal-title":"J Clin Invest"},{"issue":"4","key":"6_CR70","first-page":"353","volume":"106","author":"A Grauer","year":"1998","unstructured":"Grauer A, Raue F, Ziegler R (1998) Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin. Exp Clin Endocrinol Diabetes 106(4):353\u2013359","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"6_CR71","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1472-6890-13-27","volume":"13","author":"C Guesgen","year":"2013","unstructured":"Guesgen C, Willms A, Zwad A, Waldeck S, Wieler H, Schwab R (2013) Investigation of factors potentially influencing calcitonin levels in the screening and follow-up for medullary thyroid carcinoma: a cautionary note. BMC Clin Pathol 13(1):27","journal-title":"BMC Clin Pathol"},{"issue":"1","key":"6_CR72","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1089\/10507250150500694","volume":"11","author":"JR Hahm","year":"2001","unstructured":"Hahm JR, Lee MS, Min YK, Lee MK, Kim KW, Nam SJ et al (2001) Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases. Thyroid 11(1):73\u201380","journal-title":"Thyroid"},{"issue":"1","key":"6_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1\u2013133","journal-title":"Thyroid"},{"issue":"3","key":"6_CR75","first-page":"390","volume":"93","author":"H Heath 3rd","year":"1979","unstructured":"Heath H 3rd, Sizemore GW (1979) Immunochemical heterogeneity of calcitonin in tumor, tumor venous effluent, and peripheral blood of patients with medullary thyroid carcinoma. J Lab Clin Med 93(3):390\u2013401","journal-title":"J Lab Clin Med"},{"issue":"4","key":"6_CR76","first-page":"299","volume":"1","author":"PF Hirsch","year":"2001","unstructured":"Hirsch PF, Lester GE, Talmage RV (2001) Calcitonin, an enigmatic hormone does it have a function? J Musculoskelet Neuronal Interact 1(4):299\u2013305","journal-title":"J Musculoskelet Neuronal Interact"},{"issue":"9","key":"6_CR77","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1056\/NEJM198708273170904","volume":"317","author":"DL Hurley","year":"1987","unstructured":"Hurley DL, Tiegs RD, Wahner HW, Heath H 3rd (1987) Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med 317(9):537\u2013541","journal-title":"N Engl J Med"},{"issue":"9","key":"6_CR79","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1373\/clinchem.2016.270009","volume":"63","author":"GJ Kahaly","year":"2017","unstructured":"Kahaly GJ, Algeciras-Schimnich A, Davis TE, Diana T, Feldkamp J, Karger S et al (2017) United States and European multicenter prospective study for the analytical performance and clinical validation of a novel sensitive fully automated immunoassay for calcitonin. Clin Chem 63(9):1489\u20131496","journal-title":"Clin Chem"},{"issue":"2","key":"6_CR80","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2265.1979.tb01361.x","volume":"10","author":"JA Kanis","year":"1979","unstructured":"Kanis JA, Adams ND, Cecchettin M, Luizetto G, Gaspar S, Heynen G (1979) Ethanol induced secretion of calcitonin in chronic renal disease. Clin Endocrinol 10(2):155\u2013161","journal-title":"Clin Endocrinol"},{"issue":"4","key":"6_CR81","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/eje.1.01867","volume":"152","author":"D Kapoor","year":"2005","unstructured":"Kapoor D, Jones TH (2005) Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 152(4):491\u2013499","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"6_CR82","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-2004-815727","volume":"112","author":"W Karges","year":"2004","unstructured":"Karges W, Dralle H, Raue F, Mann K, Reiners C, Grussendorf M et al (2004) German Society for Endocrinology (DGE)\u2014thyroid section. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 112(1):52\u201358","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"7","key":"6_CR84","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1507\/endocrj.EJ16-0107","volume":"63","author":"M Kihara","year":"2016","unstructured":"Kihara M, Miyauchi A, Kudo T, Hirokawa M, Miya A (2016) Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay before\/after total thyroidectomy in Japanese patients with thyroid diseases other than medullary thyroid carcinoma. Endocr J 63(7):627\u2013632","journal-title":"Endocr J"},{"issue":"2","key":"6_CR85","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00595-017-1578-7","volume":"48","author":"M Kihara","year":"2018","unstructured":"Kihara M, Miyauchi A, Kudo T, Hirokawa M, Miya A (2018) Serum calcitonin reference values for calcium stimulation tests by electrochemiluminescence immunoassay in Japanese men with non-medullary thyroid carcinoma. Surg Today 48(2):223\u2013228","journal-title":"Surg Today"},{"issue":"3","key":"6_CR86","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1089\/thy.2013.0121","volume":"24","author":"HK Kim","year":"2014","unstructured":"Kim HK, Bae WK, Choi YD, Shim HJ, Yoon JH, Kang HC (2014) Serum calcitonin may falsely estimate tumor burden in chronic hypercalcemia: a case of prostatic and multiple bone metastases from medullary thyroid cancer. Thyroid 24(3):599\u2013603","journal-title":"Thyroid"},{"issue":"3","key":"6_CR87","doi-asserted-by":"publisher","first-page":"161","DOI":"10.7326\/0003-4819-121-3-199408010-00001","volume":"121","author":"EC Klinkenberg-Knol","year":"1994","unstructured":"Klinkenberg-Knol EC, Festen HP, Jansen JB, Lamers CB, Nelis F, Snel P et al (1994) Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 121(3):161\u2013167","journal-title":"Ann Intern Med"},{"issue":"9","key":"6_CR88","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1089\/thy.1999.9.943","volume":"9","author":"H Kotzmann","year":"1999","unstructured":"Kotzmann H, Schmidt A, Scheuba C, Kaserer K, Watschinger B, S\u00f6regi G et al (1999) Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis as indicators of medullary carcinoma. Thyroid 9(9):943\u2013947","journal-title":"Thyroid"},{"issue":"3","key":"6_CR89","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1373\/clinchem.2010.151688","volume":"57","author":"J Kratzsch","year":"2011","unstructured":"Kratzsch J, Petzold A, Raue F, Reinhardt W, Br\u00f6cker-Preuss M, G\u00f6rges R et al (2011) Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. Clin Chem 57(3):467\u2013474","journal-title":"Clin Chem"},{"issue":"11","key":"6_CR90","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1515\/cclm-2021-0428","volume":"59","author":"J Kratzsch","year":"2021","unstructured":"Kratzsch J, Willenberg A, Frank-Raue K, Kempin U, Rockt\u00e4schel J, Raue F (2021) Procalcitonin measured by three different assays is an excellent tumor marker for the follow-up of patients with medullary thyroid carcinoma. Clin Chem Lab Med 59(11):1861\u20131868","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"6_CR91","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/jc.2005-1429","volume":"91","author":"R Leboeuf","year":"2006","unstructured":"Leboeuf R, Langlois M, Martin M, Ahnadi CE, Fink GD (2006) \u201cHook effect\u201d in calcitonin Immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: case report and review of the literature. J Clin Endocrinol Metab 91(2):361\u2013364","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6_CR92","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1210\/jcem-45-3-528","volume":"45","author":"JC Lee","year":"1977","unstructured":"Lee JC, Parthemore JG, Deftos LJ (1977) Immunochemical heterogeneity of calcitonin in renal failure. J Clin Endocrinol Metab 45(3):528\u2013533","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6_CR93","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1210\/jc.2007-2792","volume":"93","author":"A Machens","year":"2008","unstructured":"Machens A, Hauptmann S, Dralle H (2008) Medullary thyroid cancer responsiveness to pentagastrin stimulation: an early surrogate parameter of tumor dissemination? J Clin Endocrinol Metab 93(6):2234\u20132238","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"6_CR94","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1210\/jc.2014-1278","volume":"99","author":"A Machens","year":"2014","unstructured":"Machens A, Lorenz K, Dralle H (2014) Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer. J Clin Endocrinol Metab 99(8):2986\u20132994","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"6_CR95","first-page":"230","volume":"38","author":"I MacIntyre","year":"1984","unstructured":"MacIntyre I, Girgis SI, Hillyard CJ (1984) Essential steps in the measurement of normal circulating levels of calcitonin. Biomed Pharmacother 38(5):230\u2013234","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"6_CR96","first-page":"250","volume":"19","author":"ME Mart\u00ednez","year":"1983","unstructured":"Mart\u00ednez ME, Miguel JL, G\u00f3mez P, Selgas R, Salinas M, Gentil M et al (1983) Plasma calcitonin concentration in patients treated with chronic dialysis: differences between hemodialysis and CAPD. Clin Nephrol 19(5):250\u2013253","journal-title":"Clin Nephrol"},{"issue":"4064","key":"6_CR97","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1126\/science.178.4064.999","volume":"178","author":"SJ Marx","year":"1972","unstructured":"Marx SJ, Woodward CJ, Aurbach GD (1972) Calcitonin receptors of kidney and bone. Science 178(4064):999\u20131001","journal-title":"Science"},{"issue":"5","key":"6_CR98","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1210\/jc.2013-4088","volume":"99","author":"C Mian","year":"2014","unstructured":"Mian C, Perrino M, Colombo C, Cavedon E, Pennelli G, Ferrero S et al (2014) Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety. J Clin Endocrinol Metab 99(5):1656\u20131664","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6_CR99","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1365-2265.2009.03759.x","volume":"73","author":"F Milone","year":"2010","unstructured":"Milone F, Ramundo V, Chiofalo MG, Severino R, Paciolla I, Pezzullo L et al (2010) Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Clin Endocrinol 73(1):85\u201388","journal-title":"Clin Endocrinol"},{"issue":"7834","key":"6_CR100","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41586-020-2890-8","volume":"587","author":"LM Moreira","year":"2020","unstructured":"Moreira LM, Takawale A, Hulsurkar M, Menassa DA, Antanaviciute A, Lahiri SK et al (2020) Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia. Nature 587(7834):460\u2013465","journal-title":"Nature"},{"issue":"2","key":"6_CR101","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/jalm\/jfab162","volume":"7","author":"G Moretti","year":"2022","unstructured":"Moretti G, Troiani E, Sarlo F, Baroni S, Urbani A (2022) Analytical performance evaluation of a new calcitonin assay. J Appl Lab Med 7(2):568\u2013574","journal-title":"J Appl Lab Med"},{"issue":"5","key":"6_CR102","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1507\/endocrj1954.28.583","volume":"28","author":"S Morimoto","year":"1981","unstructured":"Morimoto S, Okada Y, Onishi T, Takai S, Miyauchi A, Lee S et al (1981) Heterogeneity of plasma and urinary immunoreactive calcitonin in patients with medullary carcinoma of the thyroid. Endocrinol Jpn 28(5):583\u2013594","journal-title":"Endocrinol Jpn"},{"issue":"1","key":"6_CR103","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0009-8981(88)90365-8","volume":"174","author":"P Mott\u00e9","year":"1988","unstructured":"Mott\u00e9 P, Vauzelle P, Gardet P, Ghillani P, Caillou B, Parmentier C et al (1988) Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies. Clin Chim Acta 174(1):35\u201354","journal-title":"Clin Chim Acta"},{"issue":"2","key":"6_CR104","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000182630","volume":"31","author":"H Mulder","year":"1982","unstructured":"Mulder H, Silberbusch J, Hackeng WH, Koorevaar G, den Ottolander GJ (1982) Enhanced calcitonin release in chronic renal failure depending on the absence of severe secondary hyperparathyroidism. Nephron 31(2):123\u2013128","journal-title":"Nephron"},{"issue":"5\u20136","key":"6_CR105","first-page":"288","volume":"36","author":"H Mulder","year":"1990","unstructured":"Mulder H, Hackeng WH, vd Lely AJ, Siersema-Smallegange M (1990) Change of serum calcitonin in patients receiving glucocorticoids: an acute phase study. Neth J Med 36(5\u20136):288\u2013290","journal-title":"Neth J Med"},{"issue":"1","key":"6_CR106","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/cancers16010210","volume":"16","author":"C Mura","year":"2024","unstructured":"Mura C, Rodia R, Corrias S, Cappai A, Lai ML, Canu GL (2024) Diffuse C-cells hyperplasia is the source of false positive calcitonin measurement in FNA washout fluids of thyroid nodules: a rational clinical approach to avoiding unnecessary surgery. Cancers (Basel) 16(1):210","journal-title":"Cancers (Basel)"},{"issue":"1","key":"6_CR107","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1152\/physrev.00066.2017","volume":"99","author":"D Naot","year":"2019","unstructured":"Naot D, Musson DS, Cornish J (2019) The activity of peptides of the calcitonin family in bone. Physiol Rev 99(1):781\u2013805","journal-title":"Physiol Rev"},{"issue":"1","key":"6_CR108","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1530\/eje.0.1320075","volume":"132","author":"P Niccoli","year":"1995","unstructured":"Niccoli P, Brunet P, Roubicek C, Roux F, Baudin E, Lejeune PJ et al (1995) Abnormal calcitonin basal levels and pentagastrin response in patients with chronic renal failure on maintenance hemodialysis. Eur J Endocrinol 132(1):75\u201381","journal-title":"Eur J Endocrinol"},{"key":"6_CR1080","doi-asserted-by":"crossref","unstructured":"Niederle MB, Scheuba C, Gessl A, Li S, Koperek O, Bieglmayer C, Riss P, Selberherr A, Niederle B. (2018) Calcium-stimulated calcitonin - The \u201cnew standard\u201d in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an \u201cold test\u201d. Biochem Med (Zagreb) 28:030710","DOI":"10.11613\/BM.2018.030710"},{"key":"6_CR1090","doi-asserted-by":"crossref","unstructured":"Niederle MB, Scheuba C, Gessl A, Li S, Koperek O, Bieglmayer C, Riss P, Selberherr A, Niederle Niederle MB, Scheuba C, Riss P, Selberherr A, Koperek O, Niederle B (2020) Early Diagnosis of Medullary Thyroid Cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays? Thyroid 30:974\u2013984","DOI":"10.1089\/thy.2019.0785"},{"issue":"4","key":"6_CR109","first-page":"826","volume":"78","author":"F Pacini","year":"1994","unstructured":"Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G et al (1994) Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78(4):826\u2013829","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"6_CR110","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1530\/eje.1.02158","volume":"154","author":"F Pacini","year":"2006","unstructured":"Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W et al (2006) European thyroid cancer taskforce. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154(6):787\u2013803. Erratum in: Eur J Endocrinol 155:385","journal-title":"Eur J Endocrinol"},{"issue":"19","key":"6_CR111","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/BF03349197","volume":"29","author":"PD Papapetrou","year":"2006","unstructured":"Papapetrou PD, Polymeris A, Karga H, Vaiopoulos G (2006) Heterophilic antibodies causing falsely high serum calcitonin values. J Endocrinol Investig 29(19):919\u2013923","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"6_CR112","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1210\/jcem-39-1-108","volume":"39","author":"JG Parthemore","year":"1974","unstructured":"Parthemore JG, Bronzert D, Roberts G, Deftos LJ (1974) A short calcium infusion in the diagnosis of medullary thyroid carcinoma. J Clin Endocrinol Metab 39(1):108\u2013111","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6_CR113","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/cen.12001","volume":"78","author":"G Pina","year":"2013","unstructured":"Pina G, Dubois S, Murat A, Berger N, Niccoli P, Peix JL et al (2013) Is basal ultrasensitive measurement of calcitonin capable of substituting for the pentagastrin-stimulation test? Clin Endocrinol 78(3):358\u2013364","journal-title":"Clin Endocrinol"},{"issue":"4","key":"6_CR114","doi-asserted-by":"publisher","first-page":"304","DOI":"10.14310\/horm.2002.1322","volume":"10","author":"A Polymeris","year":"2011","unstructured":"Polymeris A, Papapetrou PD, Papandroulaki F, Thanou S (2011) Hyperinsulinemia during oral glucose tolerance test and high normal serum cortisol are associated with increased secretion of calcitonin in normal subjects. Hormones (Athens) 10(4):304\u2013312","journal-title":"Hormones (Athens)"},{"key":"6_CR115","unstructured":"Reference Institute for Bioanalytics (RfB): German Survey for CTN (n.d.). https:\/\/www.rfb.bio\/cgi\/surveys?searchType=analyte&rv_type=all&analyte=Calcitonin&year=2024. Accessed 29 Apr 2024"},{"key":"6_CR116","unstructured":"Reference Institute for Bioanalytics (RfB): German Survey for PCTN (n.d.). https:\/\/www.rfb.bio\/cgi\/surveys?searchType=analyte&rv_type=all&analyte=PCT&year=2024. Accessed 29 Apr 2024"},{"issue":"4","key":"6_CR117","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1089\/thy.2008.0102","volume":"19","author":"T Rink","year":"2009","unstructured":"Rink T, Truong PN, Schroth HJ, Diener J, Zimny M, Gr\u00fcnwald F (2009) Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease. Thyroid 19(4):327\u2013332","journal-title":"Thyroid"},{"key":"6_CR118","unstructured":"Roche Cobas, calcitonin product characteristic (n.d.). http:\/\/www.cobas.com\/home\/product\/clinical-and-immunochemistry-testing\/elecsys-calcitonin.html. Accessed 24 Mar 2015"},{"issue":"3\u20134","key":"6_CR119","first-page":"191","volume":"48","author":"B Saller","year":"2002","unstructured":"Saller B, G\u00f6rges R, Reinhardt W, Haupt K, Janssen OE, Mann K (2002) Sensitive calcitonin measurement by two-site immunometric assays: implications for calcitonin screening in nodular thyroid disease. Clin Lab 48(3\u20134):191\u2013200","journal-title":"Clin Lab"},{"issue":"6","key":"6_CR120","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1067\/msy.2099.102268","volume":"126","author":"C Scheuba","year":"1999","unstructured":"Scheuba C, Kaserer K, Weinh\u00e4usl A, Pandev R, Kaider A, Passler C et al (1999) Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Surgery 126(6):1089\u20131095","journal-title":"Surgery"},{"issue":"1","key":"6_CR121","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0009-8981(93)90253-Z","volume":"215","author":"S Schifter","year":"1993","unstructured":"Schifter S (1993) A new highly sensitive radioimmunoassay for human calcitonin useful for physiological studies. Clin Chim Acta 215(1):99\u2013109","journal-title":"Clin Chim Acta"},{"issue":"2","key":"6_CR122","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/0006-291X(74)91015-8","volume":"61","author":"FR Singer","year":"1974","unstructured":"Singer FR, Habener JF (1974) Multiple immunoreactive forms of calcitonin in human plasma. Biochem Biophys Res Commun 61(2):710\u2013716","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"6_CR123","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1172\/JCI108012","volume":"55","author":"GW Sizemore","year":"1975","unstructured":"Sizemore GW, Hpeath H 3rd, Larson JM (1975) Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma. J Clin Invest 55(5):1111\u20131118","journal-title":"J Clin Invest"},{"issue":"1","key":"6_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0009-8981(77)90113-9","volume":"76","author":"RH Snider","year":"1977","unstructured":"Snider RH, Silva OL, Moor CF, Becker KL (1977) Immunochemical heterogeneity of calcitonin in man: effect on radioimmunoassay. Clin Chimica Acta 76(1):1\u201314","journal-title":"Clin Chimica Acta"},{"issue":"6","key":"6_CR125","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000512107","volume":"93","author":"J Sonntag","year":"2020","unstructured":"Sonntag J, Vogel M, Geserick M, Eckelt F, K\u00f6rner A, Raue F et al (2020) Age-related Association of Calcitonin with parameters of anthropometry, bone and calcium metabolism during childhood. Horm Res Paediatr 93(6):361\u2013370","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"6_CR126","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1515\/CCLM.2004.077","volume":"42","author":"G Steinbach","year":"2004","unstructured":"Steinbach G, Rau B, Debard AL, Javourez JF, Bienvenu J, Ponzio A et al (2004) Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor system. Clin Chem Lab Med 42(4):440\u2013449","journal-title":"Clin Chem Lab Med"},{"issue":"11","key":"6_CR127","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1507\/endocrj.EJ17-0238","volume":"64","author":"A Suzuki","year":"2017","unstructured":"Suzuki A, Hirokawa M, Takada N, Higuchi M, Ito A, Yamao N (2017) Fine-needle aspiration cytology for medullary thyroid carcinoma: a single institutional experience in Japan. Endocr J 64(11):1099\u20131104","journal-title":"Endocr J"},{"issue":"2","key":"6_CR128","first-page":"105","volume":"25","author":"J Tate","year":"2004","unstructured":"Tate J, Ward G (2004) Interferences in immunoassay. Clin Biochem Rev 25(2):105\u2013120","journal-title":"Clin Biochem Rev"},{"issue":"12","key":"6_CR129","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1210\/jc.2014-1869","volume":"99","author":"U Thiem","year":"2014","unstructured":"Thiem U, Marculescu R, Cejka D, Gessl A, Borchhardt K (2014) Low-dose calcium versus pentagastrin for stimulation of calcitonin in chronic hemodialysis patients: a pilot study. J Clin Endocrinol Metab 99(12):4704\u20134711","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"6_CR130","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1210\/jcem-57-4-749","volume":"57","author":"PH Tobler","year":"1983","unstructured":"Tobler PH, Tschopp FA, Dambacher MA, Born W, Fischer JA (1983) Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients. J Clin Endocrinol Metab 57(4):749\u2013754","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"6_CR131","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1590\/S1807-59322009000700015","volume":"64","author":"SP Toledo","year":"2009","unstructured":"Toledo SP, Louren\u00e7o DM Jr, Santos MA, Tavares MR, Toledo RA, Correia-Deur JE (2009) Hypercalcitoninemia is not pathognomonic of medullary thyroid carcinoma. Clinics (Sao Paulo) 64(7):699\u2013706","journal-title":"Clinics (Sao Paulo)"},{"issue":"8","key":"6_CR132","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1515\/CCLM.2007.328","volume":"45","author":"M Tommasi","year":"2007","unstructured":"Tommasi M, Raspanti S (2007a) Hook effect in calcitonin immunoradiometric assay. Clin Chem Lab Med 45(8):1073\u20131074","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"6_CR133","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1373\/clinchem.2006.083733","volume":"53","author":"M Tommasi","year":"2007","unstructured":"Tommasi M, Raspanti S (2007b) Comparison of calcitonin determinations by polyclonal and monoclonal IRMAs. Clin Chem 53(4):798\u2013799","journal-title":"Clin Chem"},{"key":"6_CR134","doi-asserted-by":"crossref","unstructured":"Trimboli P, Giovanella L (2015a) Serum calcitonin negative medullary thyroid carcinoma: a systematic review of the literature. Clin Chem Lab Med 53(10):1507\u20131514","DOI":"10.1515\/cclm-2015-0058"},{"key":"6_CR135","doi-asserted-by":"crossref","unstructured":"Trimboli P, Treglia G, Guidobaldi L, Romanelli F, Nigri G, Valabrega S et al (2015b) Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis. Clin Endocrinol 82(2):280\u2013285","DOI":"10.1111\/cen.12563"},{"issue":"1","key":"6_CR136","first-page":"60","volume":"83","author":"P Trimboli","year":"2024","unstructured":"Trimboli P, Valderrabano P, Pitoia F, Piccardo A, Bojunga J (2024a) Appropriate and mindful measurement of serum calcitonin in patients with thyroid nodules. A white paper Endocrine 83(1):60\u201364","journal-title":"A white paper Endocrine"},{"key":"6_CR137","doi-asserted-by":"publisher","first-page":"1278816","DOI":"10.3389\/fonc.2024.1278816","volume":"14","author":"P Trimboli","year":"2024","unstructured":"Trimboli P, Peloni G, Confalonieri D, Gamarra E, Piticchio T, Frasca F et al (2024b) Determinants of circulating calcitonin value: analysis of thyroid features, demographic data, anthropometric characteristics, comorbidities, medications, and smoking habits in a population with histological full exclusion of medullary thyroid carcinoma. Front Oncol 14:1278816","journal-title":"Front Oncol"},{"issue":"2","key":"6_CR138","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3109\/00365513.2010.547214","volume":"71","author":"J Uhrova","year":"2011","unstructured":"Uhrova J, Brodska H, Vanickova Z, Benakova H, Zima T (2011) Procalcitonin interference in an immunometric calcitonin assay. Scand J Clin Lab Invest 71(2):157\u2013162","journal-title":"Scand J Clin Lab Invest"},{"key":"6_CR139","doi-asserted-by":"publisher","DOI":"10.20945\/2359-4292-2023-0074","volume":"68","author":"MC Unal","year":"2023","unstructured":"Unal MC, Bayraktar AC, Uslu T, Yener S (2023) Multiple immunoassay interference in a patient with falsely elevated calcitonin. Arch Endocrinol Metab 68:e230074","journal-title":"Arch Endocrinol Metab"},{"issue":"5","key":"6_CR140","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF03343874","volume":"24","author":"GI Uwaifo","year":"2001","unstructured":"Uwaifo GI, Remaley AT, Stene M, Reynolds JC, Yen PM, Snider RH et al (2001) A case of spurious hypercalcitoninemia: a cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia. J Endocrinol Investig 24(5):361\u2013369","journal-title":"J Endocrinol Investig"},{"issue":"3","key":"6_CR141","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1089\/thy.2006.0216","volume":"17","author":"MC Vantyghem","year":"2007","unstructured":"Vantyghem MC, Danel T, Marcelli-Tourvieille S, Moriau J, Leclerc L, Cardot-Bauters C et al (2007) Calcitonin levels do not decrease with weaning in chronic alcoholism. Thyroid 17(3):213\u2013217","journal-title":"Thyroid"},{"issue":"3","key":"6_CR142","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1530\/EC-21-0030","volume":"10","author":"I Vardarli","year":"2021","unstructured":"Vardarli I, Weber M, Weidemann F, F\u00fchrer D, Herrmann K, G\u00f6rges R (2021) Diagnostic accuracy of routine calcitonin measurement for the detection of medullary thyroid carcinoma in the management of patients with nodular thyroid disease: a meta-analysis. Endocr Connect 10(3):358\u2013370","journal-title":"Endocr Connect"},{"issue":"3","key":"6_CR143","first-page":"CD010159","volume":"3","author":"HH Verbeek","year":"2020","unstructured":"Verbeek HH, de Groot JWB, Sluiter WJ, Muller Kobold AC, van den Heuvel ER, Plukker JT et al (2020) Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules. Cochrane Database Syst Rev 3(3):CD010159","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"6_CR144","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1055\/s-2002-26712","volume":"34","author":"AE Vieira","year":"2002","unstructured":"Vieira AE, Mello MP, Elias LL, Lau IF, Maciel LM, Moreira AC et al (2002) Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A. Horm Metab Res 34(4):202\u2013206","journal-title":"Horm Metab Res"},{"issue":"9","key":"6_CR145","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/clinchem\/48.9.1505","volume":"48","author":"G Vitale","year":"2002","unstructured":"Vitale G, Ciccarelli A, Caraglia M, Galderisi M, Rossi R, Del Prete S et al (2002) Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin. Clin Chem 48(9):1505\u20131510","journal-title":"Clin Chem"},{"issue":"1","key":"6_CR146","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/jcem-32-1-102","volume":"32","author":"EF Voelkel","year":"1971","unstructured":"Voelkel EF, Tashjian AH Jr (1971) Measurement of thyrocalcitonin-like activity in urine of patients with medullary carcinoma. J Clin Endocrinol Metab 32(1):102\u2013109","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"6_CR147","doi-asserted-by":"publisher","first-page":"P21","DOI":"10.1055\/s-0033-1336713","volume":"121","author":"M Vogeser","year":"2013","unstructured":"Vogeser M, Kratzsch J, Otto C (2013) Thyroidectomy due to interference of serum calcitonin measurement by heterophilic antibodies. Exp Clin Endocrinol Diabetes 121(3):P21","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"6_CR148","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/cncr.24738","volume":"116","author":"MA Walter","year":"2010","unstructured":"Walter MA, Meier C, Radimerski T, Iten F, Kr\u00e4nzlin M, M\u00fcller-Brand J et al (2010) Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer. Cancer 116(1):31\u201340","journal-title":"Cancer"},{"issue":"6","key":"6_CR149","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells Jr","year":"2015","unstructured":"Wells SA Jr, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF et al (2015) American Thyroid Association guidelines task force on medullary thyroid carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid 25(6):567\u2013610","journal-title":"Thyroid"},{"issue":"12","key":"6_CR150","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1172\/JCI200217425","volume":"110","author":"M Zaidi","year":"2002","unstructured":"Zaidi M, Moonga BS, Abe E (2002) Calcitonin and bone formation: a knockout full of surprises. J Clin Invest 110(12):1769\u20131771","journal-title":"J Clin Invest"},{"issue":"4","key":"6_CR151","doi-asserted-by":"publisher","first-page":"620","DOI":"10.4158\/EP12358.OR","volume":"19","author":"AA Zayed","year":"2013","unstructured":"Zayed AA, Alzubaidi M, Atallah S, Momani MS, Al-Delaimy WK (2013) Should food intake and circadian rhythm be considered when measuring serum calcitonin level? Endocr Pract 19(4):620\u2013626","journal-title":"Endocr Pract"}],"container-title":["Recent Results in Cancer Research","Medullary Thyroid Carcinoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-80396-3_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T04:32:25Z","timestamp":1742358745000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-80396-3_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9783031803956","9783031803963"],"references-count":148,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-80396-3_6","relation":{},"ISSN":["0080-0015","2197-6767"],"issn-type":[{"value":"0080-0015","type":"print"},{"value":"2197-6767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"20 March 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}